Williams & Novak’s Abbott ABT Stock Holding History

Williams & Novak’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,320	Closed	-$667K	–	144
2025 Q4	$667K	Buy	+5,320	New	+$678K	0.5%	51

Other funds holding ABT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Williams & Novak's ABT Position: Q1 2026 in Review

Williams & Novak sold out of Abbott (ABT) in Q1 2026, closing a stake of 5,320 shares — an estimated $667K sold.

Williams & Novak first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $667K in Q4 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Williams & Novak reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Williams & Novak sold 5,320 Abbott shares in Q1 2026, an estimated $667K.
Williams & Novak first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
Williams & Novak's Abbott position peaked at $667K in Q4 2025.
3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Williams & Novak's 13F filing for Q1 2026, filed 21 Apr 2026.